Literature DB >> 22416183

Framework for assessing quality of care for inflammatory bowel disease in Sweden.

Martin Rejler1, Jörgen Tholstrup, Mattias Elg, Anna Spångéus, Boel Andersson Gäre.   

Abstract

AIM: To create and apply a framework for quality assessment and improvement in care for inflammatory bowel disease (IBD) patients.
METHODS: A framework for quality assessment and improvement was created for IBD based on two generally acknowledged quality models. The model of Donabedian (Df) offers a logistical and productive perspective and the Clinical Value Compass (CVC) model adds a management and service perspective. The framework creates a pedagogical tool to understand the balance between the dimensions of clinical care (CVC) and the components of clinical outcome (Df). The merged models create a framework of the care process dimensions as a whole, reflecting important parts of the IBD care delivery system in a local setting. Clinical and organizational quality measures were adopted from clinical experience and the literature and were integrated into the framework. Data were collected at the yearly check-up for 481 IBD patients during 2008. The application of the quality assessment framework was tested and evaluated in a local clinical IBD care setting in Jönköping County, Sweden.
RESULTS: The main outcome was the presentation of how locally-selected clinical quality measures, integrated into two complementary models to develop a framework, could be instrumental in assessing the quality of care delivered to patients with IBD. The selected quality measures of the framework noted less anemia in the population than previously reported, provided information about hospitalization rates and the few surgical procedures reported, and noted good access to the clinic.
CONCLUSION: The applied local quality framework was feasible and useful for assessing the quality of care delivered to IBD patients in a local setting.

Entities:  

Keywords:  Donabedian; Inflammatory bowel disease; Quality improvement; Quality measures; Value compass

Mesh:

Year:  2012        PMID: 22416183      PMCID: PMC3296982          DOI: 10.3748/wjg.v18.i10.1085

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Complexity science: The challenge of complexity in health care.

Authors:  P E Plsek; T Greenhalgh
Journal:  BMJ       Date:  2001-09-15

2.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

3.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 4.  The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?

Authors:  Anders Ekbom
Journal:  Inflamm Bowel Dis       Date:  2004-02       Impact factor: 5.325

5.  AGA Task Force on Quality in Practice: a national overview and implications for GI practice.

Authors:  Martin Brotman; John Irvin Allen; Stephen J Bickston; Donald R Campbell; Jeanne M Huddleston; Laura E Peterson; Phil S Schoenfeld; Cary S Sennett; Jeff R Willis
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

6.  Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.

Authors:  C Carli; A G C Ehlin; L Klareskog; S Lindblad; S M Montgomery
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

7.  Are patients with inflammatory bowel disease receiving optimal care?

Authors:  Sarathchandra I Reddy; Sonia Friedman; Jennifer J Telford; Lisa Strate; Rie Ookubo; Peter A Banks
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

8.  Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.

Authors:  C J Metge; J F Blanchard; S Peterson; C N Bernstein
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

Review 9.  Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature.

Authors:  Alisa Wilson; Eileen Reyes; Josh Ofman
Journal:  Am J Med       Date:  2004-04-05       Impact factor: 4.965

10.  A national survey on the patterns of treatment of inflammatory bowel disease in Canada.

Authors:  Robert J Hilsden; Marja J Verhoef; Allan Best; Gaia Pocobelli
Journal:  BMC Gastroenterol       Date:  2003-06-05       Impact factor: 3.067

View more
  6 in total

Review 1.  Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  Approaches to improve quality of care in inflammatory bowel diseases.

Authors:  Rajesh Shah; Jason K Hou
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  The new frontier: Certifying quality standards in the inflammatory bowel disease care.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2021-07-10       Impact factor: 6.866

4.  An academic perspective of participation in healthcare redesign.

Authors:  Sarah Jane Prior; Carey Mather; Andrea Miller; Steven Campbell
Journal:  Health Res Policy Syst       Date:  2019-11-20

5.  Which Contributes to Clinical Performance: Academic Output or Person-Environment Fit?

Authors:  Minye Dong; Yuyin Xiao; Chenshu Shi; Wu Zeng; Fan Wu; Guohong Li
Journal:  Front Public Health       Date:  2022-03-04

Review 6.  Inflammatory bowel disease: an expanding global health problem.

Authors:  Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2013-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.